{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Duex J"],"funding":["NCI NIH HHS"],"pagination":["1195"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10969618"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(6)"],"pubmed_abstract":["The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer."],"journal":["Cancers"],"pubmed_title":["CD44 in Bladder Cancer."],"pmcid":["PMC10969618"],"funding_grant_id":["R01-CA75115"],"pubmed_authors":["Theodorescu D","Duex J"],"additional_accession":[]},"is_claimable":false,"name":"CD44 in Bladder Cancer.","description":"The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2025-04-21T21:27:54.119Z","creation":"2025-04-05T18:24:48.983Z"},"accession":"S-EPMC10969618","cross_references":{"pubmed":["38539529"],"doi":["10.3390/cancers16061195"]}}